179 related articles for article (PubMed ID: 8371149)
41. Marked improvement of glucose homeostasis in diabetic ob/ob mice given oral vanadate.
Brichard SM; Bailey CJ; Henquin JC
Diabetes; 1990 Nov; 39(11):1326-32. PubMed ID: 2227106
[TBL] [Abstract][Full Text] [Related]
42. Exendin-4 reduces glycemia by increasing liver glucokinase activity: an insulin independent effect.
Dhanesha N; Joharapurkar A; Shah G; Dhote V; Kshirsagar S; Bahekar R; Jain M
Pharmacol Rep; 2012; 64(1):140-9. PubMed ID: 22580530
[TBL] [Abstract][Full Text] [Related]
43. Nardostachys jatamansi DC Extract Alleviates Insulin Resistance and Regulates Glucose Metabolism in C57BL/KsJ-db/db Mice Through the AMP-Activated Protein Kinase Signaling Pathway.
You HN; Park MH; Hwang SY; Han JS
J Med Food; 2018 Apr; 21(4):324-331. PubMed ID: 29630449
[TBL] [Abstract][Full Text] [Related]
44. The Effects of Altered Endometrial Glucose Homeostasis on Embryo Implantation in Type 2 Diabetic Mice.
Ma YD; Cui ZH; Zhao D; Wang YC; Zhang LX; Zhang XQ; Guo WJ; Yuan DZ; Zhang JH; Yue LM; Nie L
Reprod Sci; 2021 Mar; 28(3):703-714. PubMed ID: 33151524
[TBL] [Abstract][Full Text] [Related]
45. Ferulic acid exerts its antidiabetic effect by modulating insulin-signalling molecules in the liver of high-fat diet and fructose-induced type-2 diabetic adult male rat.
Narasimhan A; Chinnaiyan M; Karundevi B
Appl Physiol Nutr Metab; 2015 Aug; 40(8):769-81. PubMed ID: 26201855
[TBL] [Abstract][Full Text] [Related]
46. Relationship of skeletal muscle glucose 6-phosphate to glucose disposal rate and glycogen synthase activity in insulin-resistant and non-insulin-dependent diabetic rhesus monkeys.
Ortmeyer HK; Bodkin NL; Hansen BC
Diabetologia; 1994 Feb; 37(2):127-33. PubMed ID: 8163045
[TBL] [Abstract][Full Text] [Related]
47. Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent.
Fujita T; Sugiyama Y; Taketomi S; Sohda T; Kawamatsu Y; Iwatsuka H; Suzuoki Z
Diabetes; 1983 Sep; 32(9):804-10. PubMed ID: 6354788
[TBL] [Abstract][Full Text] [Related]
48. Effect of chronic metformin treatment of hepatic and muscle glycogen metabolism in KK mice.
Reddi AS; Jyothirmayi GN
Biochem Med Metab Biol; 1992 Apr; 47(2):124-32. PubMed ID: 1515171
[TBL] [Abstract][Full Text] [Related]
49. MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase.
Zheng H; Wan J; Shan Y; Song X; Jin J; Su Q; Chen S; Lu X; Yang J; Li Q; Song Y; Li B
Theranostics; 2021; 11(16):7829-7843. PubMed ID: 34335967
[No Abstract] [Full Text] [Related]
50. Antidiabetic effects of flavonoids from Sophora flavescens EtOAc extract in type 2 diabetic KK-ay mice.
Yang X; Yang J; Xu C; Huang M; Zhou Q; Lv J; Ma X; Ke C; Ye Y; Shu G; Zhao P
J Ethnopharmacol; 2015 Aug; 171():161-70. PubMed ID: 26051831
[TBL] [Abstract][Full Text] [Related]
51. Adlay Bran Oil Suppresses Hepatic Gluconeogenesis and Attenuates Hyperlipidemia in Type 2 Diabetes Rats.
Tseng YH; Chang CW; Chiang W; Hsieh SC
J Med Food; 2019 Jan; 22(1):22-28. PubMed ID: 30673500
[TBL] [Abstract][Full Text] [Related]
52. O-prenylated flavonoid, an antidiabetes constituent in Melicope lunu-ankenda.
George S; Ajikumaran Nair S; Johnson AJ; Venkataraman R; Baby S
J Ethnopharmacol; 2015 Jun; 168():158-63. PubMed ID: 25858510
[TBL] [Abstract][Full Text] [Related]
53. Sweet potato (
Luo D; Mu T; Sun H
Food Funct; 2021 May; 12(9):4117-4131. PubMed ID: 33977940
[TBL] [Abstract][Full Text] [Related]
54. Treatment of insulin-resistant mice with the oral antidiabetic agent pioglitazone: evaluation of liver GLUT2 and phosphoenolpyruvate carboxykinase expression.
Hofmann CA; Edwards CW; Hillman RM; Colca JR
Endocrinology; 1992 Feb; 130(2):735-40. PubMed ID: 1733721
[TBL] [Abstract][Full Text] [Related]
55. Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy.
Rizza RA
Diabetes; 2010 Nov; 59(11):2697-707. PubMed ID: 20705776
[TBL] [Abstract][Full Text] [Related]
56. Benfluorex normalizes hyperglycemia and reverses hepatic insulin resistance in STZ-induced diabetic rats.
Serradas P; Blondel O; Bailbe D; Portha B
Diabetes; 1993 Apr; 42(4):564-70. PubMed ID: 8454107
[TBL] [Abstract][Full Text] [Related]
57. Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes.
Rossetti L; Giaccari A; Barzilai N; Howard K; Sebel G; Hu M
J Clin Invest; 1993 Sep; 92(3):1126-34. PubMed ID: 8397219
[TBL] [Abstract][Full Text] [Related]
58. DR-region of Na
Sun HJ; Cao L; Zhu MY; Wu ZY; Shen CY; Nie XW; Bian JS
Theranostics; 2020; 10(14):6149-6166. PubMed ID: 32483445
[TBL] [Abstract][Full Text] [Related]
59. Juzentaihoto extract suppresses adipocyte hypertrophy and improves hyperglycemia in KKAy mice.
Ishida T; Morisawa S; Iizuka M; Fujita H; Jobu K; Morita Y; Miyamura M
Pharmazie; 2020 May; 75(5):191-194. PubMed ID: 32393426
[TBL] [Abstract][Full Text] [Related]
60. MK-626, a dipeptidyl peptidase-4 inhibitor, does not improve the hyperglycemia or hyperinsulinemia of nonobese diabetic MKR mice.
Bhattacharjee A; Allister EM; Wheeler MB
Can J Physiol Pharmacol; 2012 May; 90(5):663-8. PubMed ID: 22530993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
